Shanghai Pharmaceutical announced that in 2016, Shangshi Medical, a wholly-owned subsidiary of the company, and a wholly-owned subsidiary of Chunhua Capital jointly established Zeus Investment Limited and completed the privatization of Vitaco. The company plans to jointly sell shares in Zeus Investment Limited and its subsidiaries with Chunhua Capital. Dehong Capital is the intended transferee, and the trading company is worth 397 million US dollars. The board of directors of the company has reviewed and approved it, and the parties signed the transaction contract on September 29, 2026.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.